COMPLETE TEST BANK
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRACTICAL APPROACH
4TH EDITION BY VIRGINIA POOLE
ARCANGELO|ANDREW|VERONICA|JENNIFER|CHAPTER 1-60|100% VERIFIED
ANSWERS| RATED A+|LATEST 2024/2025
,Table of Contents
UNIT 1 PRINCIPLES OF THERAPEUTICS ......................................................................................................... 4
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY .............................................................. 4
CHAPTER 2.PHARMACOKINETIC BASIS OF THERAPEUTICS AND PHARMACODYNAMIC .......................... 5
CHAPTER 3. IMPACT OF DRUG INTERACTIONS AND ADVERSE EVENTS ON THERAPEUTICS .................. 13
CHAPTER 4. PRINCIPLES OF PHARMACOTHERAPY IN PEDRIATICS ......................................................... 18
CHAPTER 5. PRINCIPLES OF PHARMACOTHERAPY IN PREGNANCY AND LACTATION ............................ 21
CHAPTER 6. PHARMACOTHERAPY PRINCIPLES IN OLDER ADULTS ......................................................... 27
CHAPTER 7 PRINCIPLES OF PHARMACOTHERAPY IN PAIN MANAGEMENT ........................................... 30
CHAPTER 8. PRINCIPLES OF ANTIMICROBIAL THERAPY .......................................................................... 34
CHAPTER 9. COMPLEMENTARY AND ALTERNATIVE MEDICINES ............................................................ 39
CHAPTER 10. PHARMACOGENOMICS ..................................................................................................... 43
UNIT 2 PHARMACOTHERAPY FOR SKIN DISORDERS ................................................................................... 46
CHAPTER 11. CONTACT DERMATITIS ...................................................................................................... 46
CHAPTER 12. FUNGAL INFECTIONS OF THE SKIN.................................................................................... 49
CHAPTER 13 VIRAL INFECTIONS OF THE SKIN ......................................................................................... 53
CHAPTER 14 BACTERIAL INFECTIONS OF THE SKIN................................................................................. 55
CHAPTER 15. PSORIASIS .......................................................................................................................... 59
CHAPTER 16. ACNE VULGARIS AND ROSACEA ........................................................................................ 61
UNIT 3 PHARMACOTHERAPY FOR EYE AND EAR DISORDERS ..................................................................... 63
CHAPTER 17 OPHTHALMIC DISORDERS .................................................................................................. 63
CHAPTER 18. OTITIS MEDIA AND OTITIS EXTERNA ................................................................................. 67
UNIT 4 PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS ............................................................ 71
CHAPTER 19. HYPERTENSION ................................................................................................................. 71
CHAPTER 20. HYPERLIPIDEMIA ............................................................................................................... 75
CHAPTER 21. CHRONIC STABLE ANGINA................................................................................................. 79
CHAPTER 22. HEART FAILURE ................................................................................................................. 85
CHAPTER 23. DYSRHYTHMIAS ................................................................................................................. 89
UNIT 5 PHARMACOTHERAPY FOR RESPIRATORY DISORDERS .................................................................... 93
CHAPTER 24. UPPER RESPIRATORY INFECTIONS .................................................................................... 93
CHAPTER 25. ASTHMA ............................................................................................................................ 96
CHAPTER 26. CHRONIC OBSTRUCTIVE PULMONARY DISEASE................................................................ 98
CHAPTER 27. BRONCHITIS AND PNEUMONIA ...................................................................................... 100
,UNIT 6 PHARMACOTHERAPY FOR GASTROINTERNAL TRACT DISORDERS ............................................... 102
CHAPTER 28. NAUSEA AND VOMITING........................................................................................... 102
CHAPTER 29. GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER DISEASE ............................ 105
CHAPTER 30. CONSTIPATION DIARRHEA AND IRRITABLE BOWEL SYNDROME .................................... 108
CHAPTER 31 INFLAMMATORY BOWEL DISEASE ................................................................................... 111
UNIT 7 PHARMACOTHERAPY FOR GENITOURINARY TRACT DISORDERS .................................................. 113
CHAPTER 32. URINARY TRACT INFECTIONS .......................................................................................... 113
CHAPTER 33. PROSTATIC DISORDERS AND ERECTILE DYSFUNCTION ................................................... 116
CHAPTER 34. OVERACTIVE BLADDER .................................................................................................... 140
CHAPTER 35. SEXUALLY TRANSMITTED INFECTIONS ............................................................................ 142
UNIT 8 PHARMACOTHERAPY FOR MUSCULOSKELETAL DISORDERS ........................................................ 145
CHAPTER 36. OSTEOARTHRITIS AND GOUT .......................................................................................... 145
CHAPTER 37. RHEUMATOID ARTHRITIS ................................................................................................ 151
UNIT 9 PHARMACOLOGY FOR NEUROLOGICAL/PSYCHOLOGICAL DISORDERS ........................................ 167
CHAPTER 38. HEADACHES ..................................................................................................................... 167
CHAPTER 39 SEIZURE DISORDERS ......................................................................................................... 171
CHAPTER 40. MAJOR DEPRESSIVE DISORDERS ..................................................................................... 175
CHAPTER 41. ANXIETY DISORDERS ....................................................................................................... 191
CHAPTER 42 INSOMNIA AND SLEEP DISORDERS .................................................................................. 229
CHAPTER 43. ATTENTION DEFICIT HYPERACTIVITY DISORDER ............................................................. 231
CHAPTER 44. ALZHEIMER’S DISEASE ..................................................................................................... 232
CHAPTER 45. PARKINSON DISEASE ....................................................................................................... 234
UNIT 10 PHARMACOTHERAPY FOR ENDOCRINE DISORDERS ................................................................... 240
CHAPTER 46. DIABETES MELLITUS ........................................................................................................ 240
CHAPTER 47. THYROID DISORDERS....................................................................................................... 248
UNIT 11 PHARMACOTHERAPY FOR IMMUNE DISORDERS ....................................................................... 252
CHAPTER 48. ALLERGIES AND ALLERGIC REACTIONS............................................................................ 252
CHAPTER 49. HUMAN IMMUNODEFICIENCY VIRUS ............................................................................. 255
UNIT 12 PHARMACOTHERAPY FOR HEMATOLOGIC DISORDERS .............................................................. 259
CHAPTER 50. PHARMACOTHERAPY FOR VENOUS THROMBOEMBOLISM PREVENTION AND
TREATMENT STROKE PREVENTION IN ATRIAL FIBRILLATION, AND THROMBOEMBOLISM PREVENTION
WITH MECHANICAL HEART VALVES ...................................................................................................... 259
CHAPTER 51. ANEMIAS ......................................................................................................................... 295
UNIT 13 PHARMACOTHERAPY IN HEALTH PROMOTION .......................................................................... 298
, CHAPTER 52. IMMUNIZATIONS ............................................................................................................ 298
CHAPTER 53. SMOKING CESSATION ..................................................................................................... 303
CHAPTER 54. WEIGHT LOSS .................................................................................................................. 306
UNIT 14 WOMEN'S HEALTH ...................................................................................................................... 308
CHAPTER 55. CONTRACEPTION............................................................................................................. 308
CHAPTER 56. MENOPAUSE ................................................................................................................... 311
CHAPTER 57. OSTEOPOROSIS ............................................................................................................... 323
CHAPTER 58. VAGINITIS ........................................................................................................................ 326
UNIT 15 INTEGRATIVE APPROACH TO PATIENT CARE .............................................................................. 328
CHAPTER 59. THE ECONOMICS OF PHARMACOTHERAPEUTICS ........................................................... 328
CHAPTER 60. INTEGRATIVE APPROACHES TO PHARMACOTHERAPY – A LOOK AT COMPLEX CASES .. 332
UNIT 1 PRINCIPLES OF THERAPEUTICS
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY
MULTIPLE CHOICE
1. NURSE PRACTITIONER PRESCRIPTIVE AUTHORITY IS REGULATED BY:
A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
C. THE STATE BOARD OF NURSING FOR EACH STATE
D. THE STATE BOARD OF PHARMACY
CORRECT ANS>C PTS: 1
2. PHYSICIAN ASSISTANT (PA) PRESCRIPTIVE AUTHORITY IS REGULATED BY:
A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
C. THE STATE BOARD OF NURSING
D. THE STATE BOARD OF MEDICAL EXAMINERS
CORRECT ANS>D PTS: 1
3. CLINICAL JUDGMENT IN PRESCRIBING INCLUDES:
PHARMACOTHERAPEUTICS FOR ADVANCED PRACTICE: A PRACTICAL APPROACH
4TH EDITION BY VIRGINIA POOLE
ARCANGELO|ANDREW|VERONICA|JENNIFER|CHAPTER 1-60|100% VERIFIED
ANSWERS| RATED A+|LATEST 2024/2025
,Table of Contents
UNIT 1 PRINCIPLES OF THERAPEUTICS ......................................................................................................... 4
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY .............................................................. 4
CHAPTER 2.PHARMACOKINETIC BASIS OF THERAPEUTICS AND PHARMACODYNAMIC .......................... 5
CHAPTER 3. IMPACT OF DRUG INTERACTIONS AND ADVERSE EVENTS ON THERAPEUTICS .................. 13
CHAPTER 4. PRINCIPLES OF PHARMACOTHERAPY IN PEDRIATICS ......................................................... 18
CHAPTER 5. PRINCIPLES OF PHARMACOTHERAPY IN PREGNANCY AND LACTATION ............................ 21
CHAPTER 6. PHARMACOTHERAPY PRINCIPLES IN OLDER ADULTS ......................................................... 27
CHAPTER 7 PRINCIPLES OF PHARMACOTHERAPY IN PAIN MANAGEMENT ........................................... 30
CHAPTER 8. PRINCIPLES OF ANTIMICROBIAL THERAPY .......................................................................... 34
CHAPTER 9. COMPLEMENTARY AND ALTERNATIVE MEDICINES ............................................................ 39
CHAPTER 10. PHARMACOGENOMICS ..................................................................................................... 43
UNIT 2 PHARMACOTHERAPY FOR SKIN DISORDERS ................................................................................... 46
CHAPTER 11. CONTACT DERMATITIS ...................................................................................................... 46
CHAPTER 12. FUNGAL INFECTIONS OF THE SKIN.................................................................................... 49
CHAPTER 13 VIRAL INFECTIONS OF THE SKIN ......................................................................................... 53
CHAPTER 14 BACTERIAL INFECTIONS OF THE SKIN................................................................................. 55
CHAPTER 15. PSORIASIS .......................................................................................................................... 59
CHAPTER 16. ACNE VULGARIS AND ROSACEA ........................................................................................ 61
UNIT 3 PHARMACOTHERAPY FOR EYE AND EAR DISORDERS ..................................................................... 63
CHAPTER 17 OPHTHALMIC DISORDERS .................................................................................................. 63
CHAPTER 18. OTITIS MEDIA AND OTITIS EXTERNA ................................................................................. 67
UNIT 4 PHARMACOTHERAPY FOR CARDIOVASCULAR DISORDERS ............................................................ 71
CHAPTER 19. HYPERTENSION ................................................................................................................. 71
CHAPTER 20. HYPERLIPIDEMIA ............................................................................................................... 75
CHAPTER 21. CHRONIC STABLE ANGINA................................................................................................. 79
CHAPTER 22. HEART FAILURE ................................................................................................................. 85
CHAPTER 23. DYSRHYTHMIAS ................................................................................................................. 89
UNIT 5 PHARMACOTHERAPY FOR RESPIRATORY DISORDERS .................................................................... 93
CHAPTER 24. UPPER RESPIRATORY INFECTIONS .................................................................................... 93
CHAPTER 25. ASTHMA ............................................................................................................................ 96
CHAPTER 26. CHRONIC OBSTRUCTIVE PULMONARY DISEASE................................................................ 98
CHAPTER 27. BRONCHITIS AND PNEUMONIA ...................................................................................... 100
,UNIT 6 PHARMACOTHERAPY FOR GASTROINTERNAL TRACT DISORDERS ............................................... 102
CHAPTER 28. NAUSEA AND VOMITING........................................................................................... 102
CHAPTER 29. GASTROESOPHAGEAL REFLUX DISEASE AND PEPTIC ULCER DISEASE ............................ 105
CHAPTER 30. CONSTIPATION DIARRHEA AND IRRITABLE BOWEL SYNDROME .................................... 108
CHAPTER 31 INFLAMMATORY BOWEL DISEASE ................................................................................... 111
UNIT 7 PHARMACOTHERAPY FOR GENITOURINARY TRACT DISORDERS .................................................. 113
CHAPTER 32. URINARY TRACT INFECTIONS .......................................................................................... 113
CHAPTER 33. PROSTATIC DISORDERS AND ERECTILE DYSFUNCTION ................................................... 116
CHAPTER 34. OVERACTIVE BLADDER .................................................................................................... 140
CHAPTER 35. SEXUALLY TRANSMITTED INFECTIONS ............................................................................ 142
UNIT 8 PHARMACOTHERAPY FOR MUSCULOSKELETAL DISORDERS ........................................................ 145
CHAPTER 36. OSTEOARTHRITIS AND GOUT .......................................................................................... 145
CHAPTER 37. RHEUMATOID ARTHRITIS ................................................................................................ 151
UNIT 9 PHARMACOLOGY FOR NEUROLOGICAL/PSYCHOLOGICAL DISORDERS ........................................ 167
CHAPTER 38. HEADACHES ..................................................................................................................... 167
CHAPTER 39 SEIZURE DISORDERS ......................................................................................................... 171
CHAPTER 40. MAJOR DEPRESSIVE DISORDERS ..................................................................................... 175
CHAPTER 41. ANXIETY DISORDERS ....................................................................................................... 191
CHAPTER 42 INSOMNIA AND SLEEP DISORDERS .................................................................................. 229
CHAPTER 43. ATTENTION DEFICIT HYPERACTIVITY DISORDER ............................................................. 231
CHAPTER 44. ALZHEIMER’S DISEASE ..................................................................................................... 232
CHAPTER 45. PARKINSON DISEASE ....................................................................................................... 234
UNIT 10 PHARMACOTHERAPY FOR ENDOCRINE DISORDERS ................................................................... 240
CHAPTER 46. DIABETES MELLITUS ........................................................................................................ 240
CHAPTER 47. THYROID DISORDERS....................................................................................................... 248
UNIT 11 PHARMACOTHERAPY FOR IMMUNE DISORDERS ....................................................................... 252
CHAPTER 48. ALLERGIES AND ALLERGIC REACTIONS............................................................................ 252
CHAPTER 49. HUMAN IMMUNODEFICIENCY VIRUS ............................................................................. 255
UNIT 12 PHARMACOTHERAPY FOR HEMATOLOGIC DISORDERS .............................................................. 259
CHAPTER 50. PHARMACOTHERAPY FOR VENOUS THROMBOEMBOLISM PREVENTION AND
TREATMENT STROKE PREVENTION IN ATRIAL FIBRILLATION, AND THROMBOEMBOLISM PREVENTION
WITH MECHANICAL HEART VALVES ...................................................................................................... 259
CHAPTER 51. ANEMIAS ......................................................................................................................... 295
UNIT 13 PHARMACOTHERAPY IN HEALTH PROMOTION .......................................................................... 298
, CHAPTER 52. IMMUNIZATIONS ............................................................................................................ 298
CHAPTER 53. SMOKING CESSATION ..................................................................................................... 303
CHAPTER 54. WEIGHT LOSS .................................................................................................................. 306
UNIT 14 WOMEN'S HEALTH ...................................................................................................................... 308
CHAPTER 55. CONTRACEPTION............................................................................................................. 308
CHAPTER 56. MENOPAUSE ................................................................................................................... 311
CHAPTER 57. OSTEOPOROSIS ............................................................................................................... 323
CHAPTER 58. VAGINITIS ........................................................................................................................ 326
UNIT 15 INTEGRATIVE APPROACH TO PATIENT CARE .............................................................................. 328
CHAPTER 59. THE ECONOMICS OF PHARMACOTHERAPEUTICS ........................................................... 328
CHAPTER 60. INTEGRATIVE APPROACHES TO PHARMACOTHERAPY – A LOOK AT COMPLEX CASES .. 332
UNIT 1 PRINCIPLES OF THERAPEUTICS
CHAPTER 1 ISSUES FOR THE PRACTITIONER IN DRUG THERAPY
MULTIPLE CHOICE
1. NURSE PRACTITIONER PRESCRIPTIVE AUTHORITY IS REGULATED BY:
A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
C. THE STATE BOARD OF NURSING FOR EACH STATE
D. THE STATE BOARD OF PHARMACY
CORRECT ANS>C PTS: 1
2. PHYSICIAN ASSISTANT (PA) PRESCRIPTIVE AUTHORITY IS REGULATED BY:
A. THE NATIONAL COUNCIL OF STATE BOARDS OF NURSING
B. THE U.S. DRUG ENFORCEMENT ADMINISTRATION
C. THE STATE BOARD OF NURSING
D. THE STATE BOARD OF MEDICAL EXAMINERS
CORRECT ANS>D PTS: 1
3. CLINICAL JUDGMENT IN PRESCRIBING INCLUDES:
